A better understanding of the mechanisms regulating the FOXO3-FOXM1 axis, as well as their downstream transcriptional targets, may render these proteins reliable diagnostic/prognostic factors as well as crucial therapeutic targets for cancer and for overcoming chemotherapeutic drug resistance (Fig. 2). This evidence concerns the gene FOXM1 and cancer.